Kaijun Jin

Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors

E. De Clercq, C. Pannecouque, Chun-lin Zhuang, 2019, Acta pharmaceutica Sinica. B.

Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.

E. De Clercq, C. Pannecouque, Fener Chen, 2018, European journal of medicinal chemistry.

Design and synthesis of a novel series of non-nucleoside HIV-1 inhibitors bearing pyrimidine and N-substituted aromatic piperazine.

E. De Clercq, C. Pannecouque, Y. Sang, 2018, Bioorganic & medicinal chemistry letters.

Development of Bifunctional Thiourea Organocatalysts Derived from a Chloramphenicol Base Scaffold and their Use in the Enantioselective Alcoholysis of meso Cyclic Anhydrides

Haifeng Wang, Fen‐er Chen, Kaijun Jin, 2016 .

Enantioselective β-hydroxy thioesters formation via decarboxylative aldol reactions of malonic acid half thioesters with aldehydes promoted by chloramphenicol derived sulfonamides 1

Fen‐er Chen, Kaijun Jin, Yan Wu, 2017 .

Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains.

E. De Clercq, C. Pannecouque, Fener Chen, 2019, European journal of medicinal chemistry.

Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment.

Qian Wang, Hai Qian, Di Li, 2022, Journal of medicinal chemistry.